Study of treatments for bacterial meningitis in children
Part of Brain & nervous system clinical trials.
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a newborn or child with signs of meningitis (infection around the brain)
- The infection test results are positive in spinal fluid or blood (for common bacteria like E. coli K1, meningococcus, Hib, or pneumococcus)
- Your spinal fluid test may be positive by culture, antigen test, or a DNA test (PCR)
- If blood tests are positive, it usually also comes with abnormal white blood cells in the spinal fluid
- You have purpura fulminans (a rapidly spreading rash caused by severe infection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks cases of invasive pneumococcal disease (a serious infection) in children and newborns. It may help clinicians better understand how these infections happen and guide future prevention and treatment.
This study follows children with meningitis to see how well treatments work and what happens in the long run. If your child has a fever and signs of meningitis (like a stiff neck, headache, or rash), they may be able to join.
This study looks at the best way to treat meningitis in adults right away and then checks how people recover over time. It aims to improve care and recovery for patients.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
Hear when a new Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.